Total revenue resulting entirely from net Keflex product sales for the quarter, jumped to $2.86 million from $1.24 million in the year-ago quarter but fell ...
MiddleBrook Pharmaceuticals Inc., the Germantown-based maker of the antibiotic Keflex, reported fourth-quarter revenue of $10.5 million in fiscal 2007, ...
Revenue in 2007 was generated by sales of Keflex, a drug whose rights MiddleBrook purchased. Moxatag is the first drug MiddleBrook has developed. ...
In addition, MiddleBrook Pharmaceuticals sells its Keflex products in both capsule and powder formulations for the treatment of skin and skin structure ...
MiddleBrook Pharmaceuticals Inc., the Germantown-based maker of the antibiotic Keflex, reported fourth-quarter revenue of $10.5 million in fiscal 2007, ...
In addition, MiddleBrook Pharmaceuticals sells its Keflex products in both capsule and powder formulations for the treatment of skin and skin structure ...
The Company currently markets the Keflex(R) brand of cephalexin and has received regulatory approval for MOXATAG(TM) -- the first and only once-daily ...
The Company currently markets the Keflex(R) brand of cephalexin and has received regulatory approval for MOXATAG(TM) -- the first and only once-daily ...
He gave me an antibiotic called Keflex for a skin infection, but the pimple just got bigger, hotter, harder, and redder. Sitting was almost impossible. ...
The Company currently markets the Keflex(R) brand of cephalexin and has received regulatory approval for MOXATAG(TM) - the first and only once-daily ...